I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case. Dr. George is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy.

Sumanta Pal is an Oncologist in Newport Beach, California. Dr. Pal is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Lymphadenectomy.

Rana Mckay is a Hematologist Oncology specialist and a Hematologist in San Diego, California. Dr. Mckay is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Prostatectomy, and Nephrectomy.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Orchiectomy.

Naval Daver is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Daver is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Nicolaus Kroger practices in Hamburg, Germany. Kroger is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). Their top areas of expertise are Graft Versus Host Disease (GvHD), Myelofibrosis, Leukemia, Bone Marrow Transplant, and Bone Graft.

Antonio Gasbarrini practices in Rome, Italy. Gasbarrini is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). Their top areas of expertise are Small Bowel Bacterial Overgrowth, Viral Gastroenteritis, Helicobacter Pylori Infection, Liver Transplant, and Endoscopy.

Fabio Ciceri practices in Milan, Italy. Mr. Ciceri is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Graft.

Didier Blaise practices in Marseille, France. Mr. Blaise is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.

Christopher Kane is an Urologist in San Diego, California. Dr. Kane is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

Harriet Kluger is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Kluger is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Brain Tumor, and Nephrectomy.

Jeffrey Sosman is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Sosman is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Nephrectomy.

Jaume Capdevila practices in Barcelona, Spain. Capdevila is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). Their top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Medullary Thyroid Carcinoma, Thyroid Cancer, and Appendectomy.

David Mcdermott is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Mcdermott is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Mcdermott is currently accepting new patients.

Hideaki Miyake practices in Kobe, Japan. Miyake is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). Their top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Bladder Cancer, Nephrectomy, and Prostatectomy.

Jie Liu practices in Yuquan, China. Mr. Liu is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Cerebral Hypoxia, Liver Cancer, Diarrhea, Endoscopy, and Thyroidectomy.

Daniel Castellano practices in Madrid, Spain. Mr. Castellano is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Urothelial Cancer, Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, Cystectomy, and Orchiectomy.

Axel Grothey is a Hematologist and an Oncologist in Memphis, Tennessee. Dr. Grothey is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Colorectal Cancer, Febrile Neutropenia, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

Jean-charles Soria practices in Villejuif, France. Soria is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy.

Alessandro Antonelli practices in Verona, Italy. Antonelli is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). Their top areas of expertise are Graves Disease, Renal Cell Carcinoma (RCC), Hyperthyroidism, Nephrectomy, and Prostatectomy.